| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.082 | 0.07 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |